NET COMMERCIAL LEASENet Commercial Lease • June 16th, 2016 • Audentes Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
This Lease, effective June 1, 2017, is by and between JCN PARTNERS, A CALIFORNIA LIMITED PARTNERSHIP (“Lessor”) and AUDENTES THERAPEUTICS, INC. a Delaware corporation (“Lessee”).
EXCLUSIVE LICENSE AND COLLABORATION AGREEMENTExclusive License and Collaboration Agreement • June 16th, 2016 • Audentes Therapeutics, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
THIS EXCLUSIVE LICENSE AND COLLABORATION AGREEMENT (this “Agreement”) dated as of May 3, 2016 (the “Effective Date”), is entered into between The Trustees of the University of Pennsylvania (“Licensor” or “Penn”), and Audentes Therapeutics, Inc., a Delaware corporation (“Company”), having a place of business located at 101 Montgomery Street, Suite 2650, San Francisco, CA 94104, USA, each a “Party” and collectively “Parties”.
CONSENT TO SUBLEASE AGREEMENTConsent to Sublease Agreement • June 16th, 2016 • Audentes Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
THIS CONSENT TO SUBLEASE AGREEMENT (this “Agreement”) is made as of April 21, 2016, by and among BRITANNIA GATEWAY II LIMITED PARTNERSHIP, a Delaware limited partnership (“Landlord”), SOLAZYME, INC., a Delaware corporation (“Tenant”), and AUDENTES THERAPEUTICS, INC., a Delaware corporation (“Subtenant”).
FIRST AMENDMENT TO LICENSE AGREEMENT NO. A13169License Agreement • June 16th, 2016 • Audentes Therapeutics, Inc. • Biological products, (no disgnostic substances)
WHEREAS, the University of Florida Research Foundation, Inc., a not-for-profit corporation duly organized and existing under the laws of the State of Florida and having its principal office at 223 Grinter Hall, Gainesville, Florida 32611 U.S.A. (hereinafter referred to as “UFRF”), and Audentes Therapeutics, Inc., a corporation duly organized under the laws of the State of Delaware, and having its principal office at 101 Montgomery Street, Suite 2650, San Francisco, CA, 94104, (hereinafter referred to as “Licensee”) entered into a License Agreement effective July 28, 2015 (hereinafter “License Agreement”);
